These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27255176)

  • 21. Synthesis and evaluation of sphingoid analogs as inhibitors of sphingosine kinases.
    Kim JW; Kim YW; Inagaki Y; Hwang YA; Mitsutake S; Ryu YW; Lee WK; Ha HJ; Park CS; Igarashi Y
    Bioorg Med Chem; 2005 May; 13(10):3475-85. PubMed ID: 15848761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium.
    Mukawa K; Fujii S; Tominaga K; Yoshitake N; Abe A; Kono T; Sekikawa A; Fukui H; Ichikawa K; Tomita S; Imura J; Ono Y; Shinoda M; Hiraishi H; Fujimori T
    Oncol Rep; 2008 Feb; 19(2):393-9. PubMed ID: 18202786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors.
    Patwardhan NN; Morris EA; Kharel Y; Raje MR; Gao M; Tomsig JL; Lynch KR; Santos WL
    J Med Chem; 2015 Feb; 58(4):1879-1899. PubMed ID: 25643074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow-derived mesenchymal stem cells differentiate to hepatic myofibroblasts by transforming growth factor-β1 via sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis.
    Yang L; Chang N; Liu X; Han Z; Zhu T; Li C; Yang L; Li L
    Am J Pathol; 2012 Jul; 181(1):85-97. PubMed ID: 22609227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels.
    Kharel Y; Morris EA; Congdon MD; Thorpe SB; Tomsig JL; Santos WL; Lynch KR
    J Pharmacol Exp Ther; 2015 Oct; 355(1):23-31. PubMed ID: 26243740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signaling pathways involved in sphingosine kinase activation and sphingosine-1-phosphate release in rat myometrium in late pregnancy: role in the induction of cyclooxygenase 2.
    Serrano-Sanchez M; Tanfin Z; Leiber D
    Endocrinology; 2008 Sep; 149(9):4669-79. PubMed ID: 18723875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
    Tao R; Zhang J; Vessey DA; Honbo N; Karliner JS
    Cardiovasc Res; 2007 Apr; 74(1):56-63. PubMed ID: 17320845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
    Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
    Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sasa quelpaertensis leaf extract suppresses dextran sulfate sodium-induced colitis in mice by inhibiting the proinflammatory mediators and mitogen-activated protein kinase phosphorylation.
    Kim KM; Kim YS; Lim JY; Min SJ; Shin JH; Ko HC; Kim SJ; Lim Y; Kim Y
    Nutr Res; 2014 Oct; 34(10):894-905. PubMed ID: 25287291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
    Naito Y; Katada K; Takagi T; Tsuboi H; Isozaki Y; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
    Int J Mol Med; 2006 Jun; 17(6):997-1004. PubMed ID: 16685407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis.
    Sasaki M; Bharwani S; Jordan P; Joh T; Manas K; Warren A; Harada H; Carter P; Elrod JW; Wolcott M; Grisham MB; Alexander JS
    J Pharmacol Exp Ther; 2003 Apr; 305(1):78-85. PubMed ID: 12649355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells.
    Kawahara S; Otsuji Y; Nakamura M; Murakami M; Murate T; Matsunaga T; Kanoh H; Seishima M; Banno Y; Hara A
    Anticancer Drugs; 2013 Jun; 24(5):473-83. PubMed ID: 23426175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of gentiopicroside against dextran sodium sulfate induced colitis in mice.
    Niu YT; Zhao YP; Jiao YF; Zheng J; Yang WL; Zhou R; Niu Y; Sun T; Li YX; Yu JQ
    Int Immunopharmacol; 2016 Oct; 39():16-22. PubMed ID: 27394986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sphingosine kinase inhibitor suppresses IL-18-induced interferon-gamma production through inhibition of p38 MAPK activation in human NK cells.
    Cheon S; Song SB; Jung M; Park Y; Bang JW; Kim TS; Park H; Kim CH; Yang YH; Bang SI; Cho D
    Biochem Biophys Res Commun; 2008 Sep; 374(1):74-8. PubMed ID: 18602364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
    Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
    Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
    Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
    J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKCepsilon dependent mechanism.
    Jin ZQ; Karliner JS
    Cardiovasc Res; 2006 Sep; 71(4):725-34. PubMed ID: 16831409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats.
    Tsubouchi R; Hayashi S; Aoi Y; Nishio H; Terashima S; Kato S; Takeuchi K
    Digestion; 2006; 74(2):91-100. PubMed ID: 17143008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice.
    Peng XD; Wu XH; Chen LJ; Wang ZL; Hu XH; Song LF; He CM; Luo YF; Chen ZZ; Jin K; Lin HG; Li XL; Wang YS; Wei YQ
    J Pharmacol Exp Ther; 2010 Jan; 332(1):46-56. PubMed ID: 19828878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressive effect of berberine on experimental dextran sulfate sodium-induced colitis.
    Hong T; Yang Z; Lv CF; Zhang Y
    Immunopharmacol Immunotoxicol; 2012 Jun; 34(3):391-7. PubMed ID: 22564173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.